About
Nicolas Rousseau is a French biotech operator best evidenced as co-founder and COO of EVerZom, a Paris-based regenerative-medicine company focused on extracellular vesicle (exosome) biomanufacturing. Public sources tie him to the company's 2019 founding and its 2021 EIC Accelerator-backed scale-up. The available evidence supports a startup ecosystem role in biotech and cell-therapy infrastructure, not a fund-management or capital-owner profile.
Areas of interest
biotechregenerative medicinecell therapyextracellular vesiclesexosomesbiomanufacturing